Wei Zhou

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 3

Top Topics

Resistance Training

Signaling Pathway

Top Venues

Expert opinion on therapeutic targets

Journal of medicinal chemistry

Journal of immunology (Baltimore, Md. : 1950)

University of Florida (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Florida Aug 16 2016

United States

PHD :: IDP-Biochemistry and molecular biology

Ohio State University Aug 20 2013 - Jul 31 2016

United States

MSC :: Ohio State Biochemistry Program (OSBP)

Nankai University Sep 01 2009 - Jun 30 2013

China

BSC :: College of Life Sciences

Publications

Chen Zhou, Chunbao Sun, Wei Zhou, Tian Tian, Daniel C Schultz, Tong Wu, Mu Yu, Lizi Wu, Liya Pi, Chenglong Li
Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents. Journal of medicinal chemistry (2024)
Emily Smith, Wei Zhou, Polina Shindiapina, Said Sif, Chenglong Li, Robert A Baiocchi
Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy. Expert opinion on therapeutic targets 22 (6) (2018)
Lindsay M Webb, Stephanie A Amici, Kyle A Jablonski, Himanshu Savardekar, Amanda R Panfil, Linsen Li, Wei Zhou, Kevin Peine, Vrajesh Karkhanis, Eric M Bachelder, Kristy M Ainslie, Patrick L Green, Chenglong Li, Robert A Baiocchi, Mireia Guerau-de-Arellano
PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950) 198 (4) (2017)